WHO Pharmaceuticals Newsletter 1998, No. 09&10
(1998; 23 pages)
Índice de contenido
Abrir esta carpeta y ver su contenidoRegulatory decisions
Abrir esta carpeta y ver su contenidoDrug surveillance
Abrir esta carpeta y ver su contenidoNew developments
Cerrar esta carpetaMedical devices
Ver el documentoBlood glucose meters - recalled because of error readings: USA
Ver el documentoEpiPen epinephrine auto-injectors - recall of syringes: Switzerland
Ver el documentoMedical devices - the year 2000 problem: guidance document: USA
Ver el documentoSkin wound closure adhesive - approved: USA
Ver el documentoWeight loss device - recalled: USA
Abrir esta carpeta y ver su contenidoGeneral information
Abrir esta carpeta y ver su contenidoMedication errors
Abrir esta carpeta y ver su contenidoVeterinary medicine
 

Skin wound closure adhesive - approved: USA

United States of America. The Food and Drug Administration has approved a topical skin adhesive for holding closed the wound edges of superficial wounds (DermaBond: Closure Medical Corporation). The quick-setting glue forms a film over the wound and gradually falls off as the skin heals.

Although somewhat similar to commonly- used “Super Glues”, DermaBond is formulated to be only used topically on skin.

DermaBond is approved for use on simple, superficial wounds that are easily closed, thoroughly cleansed and not infected. If a wound is more than skin-deep, deeper layers are to be closed with sutures before applying DermaBond to hold the skin wound edges closed.

Reference: FDA Talk Paper T98-46 dated 27 August 1998.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013